首页> 外国专利> COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR

COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR

机译:联合表达肿瘤抗原的痘病毒和免疫检查点抑制剂的拮抗剂和/或激动剂治疗癌症的联合治疗

摘要

FIELD: medicine.;SUBSTANCE: proposed group of inventions relates to medicine. Disclosed is a therapeutic agent for treating a human having cancer containing recombinant orthopoxvirus MVA-BN and an antagonist of anti-PD-1, which is an antibody. Disclosed is a method of treating a human having cancer, comprising administering to a patient a recombinant orthopoxvirus MVA-BN and said antagonist.;EFFECT: proposed group of inventions provides a synergetic effect associated with recombinant orthopoxvirus and antagonist anti-PD-1.;22 cl, 23 dwg, 24 ex
机译:技术领域:药物:拟议的发明组涉及药物。公开了一种用于治疗患有癌症的人的治疗剂,所述人含有重组正痘病毒MVA-BN和作为抗体的抗PD-1拮抗剂。公开了一种治疗患有癌症的人的方法,其包括向患者施用重组正痘病毒MVA-BN和所述拮抗剂。效果:提出的一组发明提供了与重组正痘病毒和拮抗剂抗PD-1相关的协同作用。 22 cl,23 dwg,24 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号